Evidence map›Paper›PMID 30517595›Full record

ArticleArchives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists2019

Medication Management Capacity and Its Neurocognitive Correlates in Huntington's Disease.

Catherine A Sumida, Emily J Van Etten, Francesca V Lopez, David P Sheppard, Eva Pirogovsky-Turk, Jody Corey-Bloom, J Vincent Filoteo, Steven P Woods, Paul E Gilbert, Maureen Schmitter-Edgecombe

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Catherine A SumidaDepartment of Psychology, Washington State University, Pullman, WA, USA.
Emily J Van EttenDepartment of Psychology, University of Arizona, Tucson, AZ, USA.
Francesca V LopezDepartment of Clinical and Health Psychology, University of Florida, Gainesville, FL, USA.
David P SheppardDepartment of Psychology, University of Houston, Houston, TX, USA.
Eva Pirogovsky-TurkDepartment of Psychiatry, University of California San Diego, San Diego, CA, USA.
Jody Corey-BloomDepartment of Neuroscience, University of California San Diego, San Diego, CA, USA.
J Vincent FiloteoDepartment of Psychiatry, University of California San Diego, San Diego, CA, USA.
Steven P WoodsDepartment of Psychology, University of Houston, Houston, TX, USA.
Paul E GilbertDepartment of Psychology, San Diego State University, San Diego, CA, USA.
Maureen Schmitter-EdgecombeDepartment of Psychology, Washington State University, Pullman, WA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveAlthough medication management is a necessary daily activity for individuals with Huntington's disease (HD), medication management abilities and their relation to cognitive functioning have not been evaluated.

methodTwenty individuals with HD and 20 healthy adults (HA) completed the Medication Management Abilities Assessment (MMAA). Individuals with HD also completed a self-report medication management measure and neuropsychological tests assessing executive function, retrospective memory, and prospective memory.

resultsIndividuals with HD performed significantly poorer and made more undertaking errors on the MMAA as compared to HA. No group differences were found in overtaking errors. In the HD group, significant associations were found between undertaking errors and perceived medication management ability as well as between MMAA task performance and measures assessing prospective memory and executive functions.

conclusionsMedication management capacity was negatively affected in individuals with HD and may be associated with difficulty remembering to take medications in the future.

Indexed as

Executive FunctionMemoryAdultAgedAged, 80 and overCase-Control StudiesFemaleHumansHuntington DiseaseMaleMedication AdherenceMiddle AgedNeuropsychological TestsRetrospective StudiesSelf ReportEveryday functioningExecutive functioningHuntington’s diseaseLearning and memory

Identifiers

PMID30517595
PMCPMC6849462

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.